![logo](/logos/000999.SZ.webp)
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
SZSE:000999.SZ
43 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 24,464.05 | 18,079.461 | 15,319.994 | 13,637.258 | 14,701.919 | 13,427.746 | 11,119.916 | 8,981.721 | 7,900.19 | 7,276.586 | 7,801.604 | 6,891.103 | 5,525.223 | 4,365.153 | 4,852.717 | 4,316.187 | 3,397.844 | 2,867.926 | 2,969.474 | 2,461.686 | 2,674.455 | 2,165.678 | 1,867.315 | 1,828.058 | 1,476.419 | 1,425.879 | 1,109.838 |
Cost of Revenue
| 11,859.689 | 8,313.134 | 6,170.843 | 5,119.615 | 4,830.073 | 4,160.362 | 3,907.742 | 3,362.266 | 3,067.03 | 2,812.181 | 3,089.871 | 2,678.215 | 2,267.389 | 1,686.229 | 2,396.065 | 2,352.868 | 1,780.858 | 1,551.435 | 1,559.248 | 1,363.501 | 1,353.857 | 1,103.311 | 916.997 | 1,005.252 | 635.446 | 604.724 | 487.214 |
Gross Profit
| 12,604.361 | 9,766.328 | 9,149.151 | 8,517.643 | 9,871.846 | 9,267.384 | 7,212.175 | 5,619.455 | 4,833.16 | 4,464.405 | 4,711.733 | 4,212.888 | 3,257.834 | 2,678.925 | 2,456.652 | 1,963.319 | 1,616.986 | 1,316.491 | 1,410.227 | 1,098.185 | 1,320.598 | 1,062.367 | 950.317 | 822.807 | 840.973 | 821.155 | 622.624 |
Gross Profit Ratio
| 0.515 | 0.54 | 0.597 | 0.625 | 0.671 | 0.69 | 0.649 | 0.626 | 0.612 | 0.614 | 0.604 | 0.611 | 0.59 | 0.614 | 0.506 | 0.455 | 0.476 | 0.459 | 0.475 | 0.446 | 0.494 | 0.491 | 0.509 | 0.45 | 0.57 | 0.576 | 0.561 |
Reseach & Development Expenses
| 641.518 | 593.942 | 560.202 | 459.844 | 441.876 | 355.844 | 297.335 | 286.788 | 236.462 | 231.8 | 198.37 | 159.646 | 102.95 | 71.553 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 351.364 | 253.992 | 253.814 | 236.946 | 237.203 | 175.941 | 168.777 | 156.561 | 145.05 | 125.145 | 177.279 | 141.738 | 111.521 | 83.655 | 367.632 | 311.342 | 221.281 | 241.498 | 328.468 | 768.248 | 389.952 | 396.97 | 443.737 | 263.116 | 156.685 | 224.536 | 203.539 |
Selling & Marketing Expenses
| 6,965.475 | 5,076.624 | 5,021.306 | 5,015.155 | 6,550.276 | 6,468.606 | 4,750.169 | 3,279.53 | 2,677.283 | 2,412.683 | 2,410.21 | 2,199.223 | 1,758.953 | 1,355.673 | 1,165.87 | 960.688 | 814.865 | 639.387 | 695.073 | 601.877 | 502.915 | 357.571 | 348.394 | 345.809 | 445.435 | 421.809 | 268.351 |
SG&A
| 8,330.623 | 5,330.616 | 5,275.121 | 5,252.101 | 6,787.479 | 6,644.548 | 4,918.946 | 3,436.091 | 2,822.333 | 2,537.828 | 2,587.489 | 2,340.961 | 1,870.474 | 1,439.327 | 1,533.503 | 1,272.031 | 1,036.146 | 880.886 | 1,023.54 | 1,370.125 | 892.868 | 754.541 | 792.131 | 608.925 | 602.12 | 646.345 | 471.89 |
Other Expenses
| -108.172 | 792.478 | 662.24 | 625.095 | 678.326 | 15.402 | 7.793 | 175.474 | 91.916 | 39.097 | 25.734 | 75.381 | 28.1 | 74.154 | 22.213 | 16.507 | 59.741 | -13.102 | 8.453 | -9.771 | 4.543 | 9.188 | 47.443 | 59.349 | 52.229 | 46.354 | 45.948 |
Operating Expenses
| 9,080.314 | 6,717.035 | 6,497.562 | 6,337.04 | 7,907.681 | 7,550.344 | 5,661.058 | 4,291.159 | 3,555.847 | 3,243.667 | 3,291.211 | 2,950.202 | 2,325.668 | 1,759.132 | 1,553.85 | 1,309.487 | 1,051.556 | 894.419 | 1,036.537 | 1,380.556 | 909.95 | 764.351 | 797.312 | 616.062 | 605.241 | 649.491 | 474.887 |
Operating Income
| 3,524.047 | 2,947.218 | 2,457.446 | 2,070.18 | 2,529.426 | 1,703.478 | 1,510.514 | 1,293.727 | 1,442.566 | 1,228.031 | 1,411.789 | 1,262.106 | 926.838 | 962.631 | 884.966 | 634.994 | 325.569 | 258.094 | 193.268 | -649.817 | 279.791 | 185.678 | 126.72 | 196.25 | 208.264 | 143.242 | 98.518 |
Operating Income Ratio
| 0.144 | 0.163 | 0.16 | 0.152 | 0.172 | 0.127 | 0.136 | 0.144 | 0.183 | 0.169 | 0.181 | 0.183 | 0.168 | 0.221 | 0.182 | 0.147 | 0.096 | 0.09 | 0.065 | -0.264 | 0.105 | 0.086 | 0.068 | 0.107 | 0.141 | 0.1 | 0.089 |
Total Other Income Expenses Net
| 225.202 | 16.218 | -28.39 | -10.761 | 39.203 | 1.841 | -32.81 | 124.905 | 251.69 | 38.868 | 12.452 | 20.097 | 15.947 | 114.233 | 1.655 | -7.836 | -181.002 | -249.693 | -226.403 | -417.052 | -149.244 | -114.465 | 13.382 | 34.503 | 23.632 | 17.273 | -3.979 |
Income Before Tax
| 3,749.249 | 2,963.436 | 2,429.056 | 2,059.419 | 2,568.63 | 1,718.88 | 1,518.307 | 1,453.201 | 1,529.003 | 1,259.605 | 1,432.974 | 1,282.783 | 948.112 | 1,034.026 | 904.456 | 645.996 | 384.427 | 208.686 | 174.503 | -679.505 | 272.869 | 189.208 | 170.275 | 248.423 | 259.928 | 189.267 | 144.111 |
Income Before Tax Ratio
| 0.153 | 0.164 | 0.159 | 0.151 | 0.175 | 0.128 | 0.137 | 0.162 | 0.194 | 0.173 | 0.184 | 0.186 | 0.172 | 0.237 | 0.186 | 0.15 | 0.113 | 0.073 | 0.059 | -0.276 | 0.102 | 0.087 | 0.091 | 0.136 | 0.176 | 0.133 | 0.13 |
Income Tax Expense
| 580.975 | 466.425 | 348.219 | 441.89 | 429.547 | 244.009 | 191.83 | 245.442 | 254.304 | 187.463 | 218.343 | 201.693 | 132.986 | 174.923 | 142.866 | 104.854 | 100.334 | 42.13 | 59.923 | 39.311 | 49.84 | 35.759 | 46.139 | 42.666 | 29.458 | 30.201 | 28.629 |
Net Income
| 2,852.932 | 2,448.802 | 2,055.104 | 1,597.489 | 2,112.495 | 1,432.078 | 1,301.687 | 1,197.841 | 1,249.227 | 1,035.889 | 1,181.105 | 1,014.076 | 760.448 | 815.985 | 709.489 | 500.087 | 279.797 | 164.922 | 119.934 | -720.797 | 208.795 | 165.02 | 121.027 | 201.579 | 220.219 | 150.832 | 98.804 |
Net Income Ratio
| 0.117 | 0.135 | 0.134 | 0.117 | 0.144 | 0.107 | 0.117 | 0.133 | 0.158 | 0.142 | 0.151 | 0.147 | 0.138 | 0.187 | 0.146 | 0.116 | 0.082 | 0.058 | 0.04 | -0.293 | 0.078 | 0.076 | 0.065 | 0.11 | 0.149 | 0.106 | 0.089 |
EPS
| 2.91 | 2.5 | 2.1 | 1.63 | 2.14 | 1.46 | 1.33 | 1.22 | 1.28 | 1.06 | 1.13 | 1.04 | 0.78 | 0.83 | 0.72 | 0.51 | 0.29 | 0.22 | 0.12 | -0.74 | 0.21 | 0.17 | 0.12 | 0.16 | 0.22 | 0.15 | 0.1 |
EPS Diluted
| 2.91 | 2.5 | 2.1 | 1.63 | 2.14 | 1.46 | 1.33 | 1.22 | 1.28 | 1.06 | 1.13 | 1.04 | 0.78 | 0.83 | 0.72 | 0.51 | 0.29 | 0.22 | 0.12 | -0.74 | 0.21 | 0.17 | 0.12 | 0.16 | 0.22 | 0.15 | 0.1 |
EBITDA
| 4,377.759 | 3,651.173 | 3,186.931 | 2,712.774 | 3,160.261 | 2,133.964 | 1,899.537 | 1,829.53 | 1,820.792 | 1,562.352 | 1,709.577 | 1,585.11 | 1,122.288 | 1,154.978 | 1,048.748 | 771.15 | 722.023 | 491.077 | 451.887 | -385.525 | 526.86 | 425.035 | 380.562 | 420.744 | 290.508 | 171.02 | 176.741 |
EBITDA Ratio
| 0.179 | 0.202 | 0.208 | 0.199 | 0.215 | 0.159 | 0.171 | 0.204 | 0.23 | 0.215 | 0.219 | 0.23 | 0.203 | 0.265 | 0.216 | 0.179 | 0.212 | 0.171 | 0.152 | -0.157 | 0.197 | 0.196 | 0.204 | 0.23 | 0.197 | 0.12 | 0.159 |